Orthopaedic Research Day 2017

Question Title

* 1. Check appropriate title.

MD/DO

ARNP/RN/NP

PT/DPT

AT/OT

Other (please specify)

Question Title

* 2. Please rate your overall satisfaction with the organization of this meeting.

Excellent

Good

Average

Fair

Poor

Other (please specify)

Question Title

* 3. The ACCME defines commercial bias as presentations giving an unbalanced view of therapeutic options by promoting a specific proprietary business interest of a commercial interest.

Was this CME course free of commercial bias?

Yes

If no, please explain

Question Title

* 4. Did the faculty disclose significant relationships with commercial support?
(One or more of these methods: Syllabus / Opening Remarks / Verbally / On Slides)

Yes

Question Title

* 5. Please rate the quality of the meeting facilities.

Excellent

Good

Average

Fair

Poor

Question Title

* 6. How well were the Orthopaedic Research Day course objectives met?

Upon completion of the course participants should be able to:

	Significantly Met	Somewhat Met	Not Met
Discuss the current research developments in every subspecialty of orthopaedics including joint reconstruction, shoulder & elbow, trauma, foot & ankle, spine, upper extremity, oncology and sports.	Discuss the current research developments in every subspecialty of orthopaedics including joint reconstruction, shoulder & elbow, trauma, foot & ankle, spine, upper extremity, oncology and sports. Significantly Met	Discuss the current research developments in every subspecialty of orthopaedics including joint reconstruction, shoulder & elbow, trauma, foot & ankle, spine, upper extremity, oncology and sports. Somewhat Met	Discuss the current research developments in every subspecialty of orthopaedics including joint reconstruction, shoulder & elbow, trauma, foot & ankle, spine, upper extremity, oncology and sports. Not Met

Question Title

* 7. Did you meet your personal goal/objective for what you intended to get out of this course?

Significantly Met

Somewhat Met

Not Met

We encourage you to expand on your answer below:

Question Title

* 8. Do you intend to integrate what you learned at this conference into your current practice?

This activity validated my current practice; no changes will be made.

Create/revise protcols, policies and/or procedures.

Change the management and/or treatment of my patients.

Other, please specify

Question Title

* 9. Please rate the relevance of this program to your scope of practice:

Very Relevant

Relevant

Somewhat Relevant

Not Very Relevant

Irrelevant

Please explain:

Question Title

* 10. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers
SESSION I: JOINTS

	Excellent	Very Good	Good	Fair	Poor
Phillip Bell, MD - Early Survivorship and Short Term Radiographic Outcomes of a Short Femoral Stem Design	Phillip Bell, MD - Early Survivorship and Short Term Radiographic Outcomes of a Short Femoral Stem Design Excellent	Phillip Bell, MD - Early Survivorship and Short Term Radiographic Outcomes of a Short Femoral Stem Design Very Good	Phillip Bell, MD - Early Survivorship and Short Term Radiographic Outcomes of a Short Femoral Stem Design Good	Phillip Bell, MD - Early Survivorship and Short Term Radiographic Outcomes of a Short Femoral Stem Design Fair	Phillip Bell, MD - Early Survivorship and Short Term Radiographic Outcomes of a Short Femoral Stem Design Poor
Taylor Dennison, MD - Early Clinical Results of MAKO Total Knee Arthroplasty. A Novel Technique	Taylor Dennison, MD - Early Clinical Results of MAKO Total Knee Arthroplasty. A Novel Technique Excellent	Taylor Dennison, MD - Early Clinical Results of MAKO Total Knee Arthroplasty. A Novel Technique Very Good	Taylor Dennison, MD - Early Clinical Results of MAKO Total Knee Arthroplasty. A Novel Technique Good	Taylor Dennison, MD - Early Clinical Results of MAKO Total Knee Arthroplasty. A Novel Technique Fair	Taylor Dennison, MD - Early Clinical Results of MAKO Total Knee Arthroplasty. A Novel Technique Poor
Tyler Noble, DO - Patient Perception Regarding Surgical Approach for Total Hip Arthroplasty	Tyler Noble, DO - Patient Perception Regarding Surgical Approach for Total Hip Arthroplasty Excellent	Tyler Noble, DO - Patient Perception Regarding Surgical Approach for Total Hip Arthroplasty Very Good	Tyler Noble, DO - Patient Perception Regarding Surgical Approach for Total Hip Arthroplasty Good	Tyler Noble, DO - Patient Perception Regarding Surgical Approach for Total Hip Arthroplasty Fair	Tyler Noble, DO - Patient Perception Regarding Surgical Approach for Total Hip Arthroplasty Poor
Matthew Weger, MD - Patient Resiliency and its Effect on Total Hip and Knee Arthroplasty Outcomes	Matthew Weger, MD - Patient Resiliency and its Effect on Total Hip and Knee Arthroplasty Outcomes Excellent	Matthew Weger, MD - Patient Resiliency and its Effect on Total Hip and Knee Arthroplasty Outcomes Very Good	Matthew Weger, MD - Patient Resiliency and its Effect on Total Hip and Knee Arthroplasty Outcomes Good	Matthew Weger, MD - Patient Resiliency and its Effect on Total Hip and Knee Arthroplasty Outcomes Fair	Matthew Weger, MD - Patient Resiliency and its Effect on Total Hip and Knee Arthroplasty Outcomes Poor

Question Title

* 11. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers
SESSION II: SHOULDER & ELBOW

	Excellent	Very Good	Good	Fair	Poor
Adham Abdelfattah, MD - Classification for Instability after Reverse	Adham Abdelfattah, MD - Classification for Instability after Reverse Excellent	Adham Abdelfattah, MD - Classification for Instability after Reverse Very Good	Adham Abdelfattah, MD - Classification for Instability after Reverse Good	Adham Abdelfattah, MD - Classification for Instability after Reverse Fair	Adham Abdelfattah, MD - Classification for Instability after Reverse Poor
Gregory Tanner. MD -Total Shoulder Arthroplasty After 5 Year Follow-up: Does Cystic Disease of the Glenoid Increase Risk of Failure?	Gregory Tanner. MD -Total Shoulder Arthroplasty After 5 Year Follow-up: Does Cystic Disease of the Glenoid Increase Risk of Failure? Excellent	Gregory Tanner. MD -Total Shoulder Arthroplasty After 5 Year Follow-up: Does Cystic Disease of the Glenoid Increase Risk of Failure? Very Good	Gregory Tanner. MD -Total Shoulder Arthroplasty After 5 Year Follow-up: Does Cystic Disease of the Glenoid Increase Risk of Failure? Good	Gregory Tanner. MD -Total Shoulder Arthroplasty After 5 Year Follow-up: Does Cystic Disease of the Glenoid Increase Risk of Failure? Fair	Gregory Tanner. MD -Total Shoulder Arthroplasty After 5 Year Follow-up: Does Cystic Disease of the Glenoid Increase Risk of Failure? Poor
Cooper Wilson, MD - The Effect of Glenoid Bone Loss on Reverse Shoulder Arthroplasty Baseplate	Cooper Wilson, MD - The Effect of Glenoid Bone Loss on Reverse Shoulder Arthroplasty Baseplate Excellent	Cooper Wilson, MD - The Effect of Glenoid Bone Loss on Reverse Shoulder Arthroplasty Baseplate Very Good	Cooper Wilson, MD - The Effect of Glenoid Bone Loss on Reverse Shoulder Arthroplasty Baseplate Good	Cooper Wilson, MD - The Effect of Glenoid Bone Loss on Reverse Shoulder Arthroplasty Baseplate Fair	Cooper Wilson, MD - The Effect of Glenoid Bone Loss on Reverse Shoulder Arthroplasty Baseplate Poor
Joey LaMartina, MD - Making in the Treatment of Displaced Proximal Humerus Fractures: The Effect of Uncertainty on Surgical Outcomes	Joey LaMartina, MD - Making in the Treatment of Displaced Proximal Humerus Fractures: The Effect of Uncertainty on Surgical Outcomes Excellent	Joey LaMartina, MD - Making in the Treatment of Displaced Proximal Humerus Fractures: The Effect of Uncertainty on Surgical Outcomes Very Good	Joey LaMartina, MD - Making in the Treatment of Displaced Proximal Humerus Fractures: The Effect of Uncertainty on Surgical Outcomes Good	Joey LaMartina, MD - Making in the Treatment of Displaced Proximal Humerus Fractures: The Effect of Uncertainty on Surgical Outcomes Fair	Joey LaMartina, MD - Making in the Treatment of Displaced Proximal Humerus Fractures: The Effect of Uncertainty on Surgical Outcomes Poor

Question Title

* 12. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers Session III: TRAUMA

	Excellent	Very Good	Good	Fair	Poor
Brett Barrick, MD - Patella Fractures treated with Cannulated Lag Screws and FiberWire have a High Union Rate and Low Rate of Implant Removal	Brett Barrick, MD - Patella Fractures treated with Cannulated Lag Screws and FiberWire have a High Union Rate and Low Rate of Implant Removal Excellent	Brett Barrick, MD - Patella Fractures treated with Cannulated Lag Screws and FiberWire have a High Union Rate and Low Rate of Implant Removal Very Good	Brett Barrick, MD - Patella Fractures treated with Cannulated Lag Screws and FiberWire have a High Union Rate and Low Rate of Implant Removal Good	Brett Barrick, MD - Patella Fractures treated with Cannulated Lag Screws and FiberWire have a High Union Rate and Low Rate of Implant Removal Fair	Brett Barrick, MD - Patella Fractures treated with Cannulated Lag Screws and FiberWire have a High Union Rate and Low Rate of Implant Removal Poor
Joseph Christensen, MD - Orthopaedic Watercraft Injuries: Characterization of Mechanisms, Fractures, and Complications in 216 Injuries	Joseph Christensen, MD - Orthopaedic Watercraft Injuries: Characterization of Mechanisms, Fractures, and Complications in 216 Injuries Excellent	Joseph Christensen, MD - Orthopaedic Watercraft Injuries: Characterization of Mechanisms, Fractures, and Complications in 216 Injuries Very Good	Joseph Christensen, MD - Orthopaedic Watercraft Injuries: Characterization of Mechanisms, Fractures, and Complications in 216 Injuries Good	Joseph Christensen, MD - Orthopaedic Watercraft Injuries: Characterization of Mechanisms, Fractures, and Complications in 216 Injuries Fair	Joseph Christensen, MD - Orthopaedic Watercraft Injuries: Characterization of Mechanisms, Fractures, and Complications in 216 Injuries Poor
Matthew Frank, MD - Multi-Dose Prophylactic IV Antibiotics Do Not Lower the Risk of Surgical Site Infection for Isolated Closed Ankle Fractures	Matthew Frank, MD - Multi-Dose Prophylactic IV Antibiotics Do Not Lower the Risk of Surgical Site Infection for Isolated Closed Ankle Fractures Excellent	Matthew Frank, MD - Multi-Dose Prophylactic IV Antibiotics Do Not Lower the Risk of Surgical Site Infection for Isolated Closed Ankle Fractures Very Good	Matthew Frank, MD - Multi-Dose Prophylactic IV Antibiotics Do Not Lower the Risk of Surgical Site Infection for Isolated Closed Ankle Fractures Good	Matthew Frank, MD - Multi-Dose Prophylactic IV Antibiotics Do Not Lower the Risk of Surgical Site Infection for Isolated Closed Ankle Fractures Fair	Matthew Frank, MD - Multi-Dose Prophylactic IV Antibiotics Do Not Lower the Risk of Surgical Site Infection for Isolated Closed Ankle Fractures Poor
David Donohue, MD - Long Segment Geriatric Supracondylar Femur Fractures: Eliminating the “Bell-clapper Effect”	David Donohue, MD - Long Segment Geriatric Supracondylar Femur Fractures: Eliminating the “Bell-clapper Effect” Excellent	David Donohue, MD - Long Segment Geriatric Supracondylar Femur Fractures: Eliminating the “Bell-clapper Effect” Very Good	David Donohue, MD - Long Segment Geriatric Supracondylar Femur Fractures: Eliminating the “Bell-clapper Effect” Good	David Donohue, MD - Long Segment Geriatric Supracondylar Femur Fractures: Eliminating the “Bell-clapper Effect” Fair	David Donohue, MD - Long Segment Geriatric Supracondylar Femur Fractures: Eliminating the “Bell-clapper Effect” Poor

Question Title

* 13. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers
SESSION V: FOOT & ANKLE

	Excellent	Very Good	Good	Fair	Poor
Brian Perry, MD - Evaluating Traditional Triple Arthrodesis versus Modified Double Arthrodesis for Treatment of Rigid Flatfoot Deformity	Brian Perry, MD - Evaluating Traditional Triple Arthrodesis versus Modified Double Arthrodesis for Treatment of Rigid Flatfoot Deformity Excellent	Brian Perry, MD - Evaluating Traditional Triple Arthrodesis versus Modified Double Arthrodesis for Treatment of Rigid Flatfoot Deformity Very Good	Brian Perry, MD - Evaluating Traditional Triple Arthrodesis versus Modified Double Arthrodesis for Treatment of Rigid Flatfoot Deformity Good	Brian Perry, MD - Evaluating Traditional Triple Arthrodesis versus Modified Double Arthrodesis for Treatment of Rigid Flatfoot Deformity Fair	Brian Perry, MD - Evaluating Traditional Triple Arthrodesis versus Modified Double Arthrodesis for Treatment of Rigid Flatfoot Deformity Poor
Diana Young, MD - Naviculocuneiform Arthrodesis: An Analysis of Union Rate	Diana Young, MD - Naviculocuneiform Arthrodesis: An Analysis of Union Rate Excellent	Diana Young, MD - Naviculocuneiform Arthrodesis: An Analysis of Union Rate Very Good	Diana Young, MD - Naviculocuneiform Arthrodesis: An Analysis of Union Rate Good	Diana Young, MD - Naviculocuneiform Arthrodesis: An Analysis of Union Rate Fair	Diana Young, MD - Naviculocuneiform Arthrodesis: An Analysis of Union Rate Poor

Question Title

* 14. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers
SESSION V: UPPER EXTREMITY

	Excellent	Very Good	Good	Fair	Poor
Jesse Lewis, MD - Comparison of Intramedullary Screw and Plate-Screw Fixation in the Treatment of Extra-Articular Metacarpal Fractures	Jesse Lewis, MD - Comparison of Intramedullary Screw and Plate-Screw Fixation in the Treatment of Extra-Articular Metacarpal Fractures Excellent	Jesse Lewis, MD - Comparison of Intramedullary Screw and Plate-Screw Fixation in the Treatment of Extra-Articular Metacarpal Fractures Very Good	Jesse Lewis, MD - Comparison of Intramedullary Screw and Plate-Screw Fixation in the Treatment of Extra-Articular Metacarpal Fractures Good	Jesse Lewis, MD - Comparison of Intramedullary Screw and Plate-Screw Fixation in the Treatment of Extra-Articular Metacarpal Fractures Fair	Jesse Lewis, MD - Comparison of Intramedullary Screw and Plate-Screw Fixation in the Treatment of Extra-Articular Metacarpal Fractures Poor
Justin Schwartzenberger, MD - Scapholunate Ligament Reconstruction Using Tendon Autograft and 3.5 mm Forktip Interference Anchors	Justin Schwartzenberger, MD - Scapholunate Ligament Reconstruction Using Tendon Autograft and 3.5 mm Forktip Interference Anchors Excellent	Justin Schwartzenberger, MD - Scapholunate Ligament Reconstruction Using Tendon Autograft and 3.5 mm Forktip Interference Anchors Very Good	Justin Schwartzenberger, MD - Scapholunate Ligament Reconstruction Using Tendon Autograft and 3.5 mm Forktip Interference Anchors Good	Justin Schwartzenberger, MD - Scapholunate Ligament Reconstruction Using Tendon Autograft and 3.5 mm Forktip Interference Anchors Fair	Justin Schwartzenberger, MD - Scapholunate Ligament Reconstruction Using Tendon Autograft and 3.5 mm Forktip Interference Anchors Poor
Casey Gaskins, III, MD - A Biomechanical Comparison of Suture Button Suspensionplasty Versus Ligament Reconstruction with Tendon Interposition for First Carpometacarpal Arthritis	Casey Gaskins, III, MD - A Biomechanical Comparison of Suture Button Suspensionplasty Versus Ligament Reconstruction with Tendon Interposition for First Carpometacarpal Arthritis Excellent	Casey Gaskins, III, MD - A Biomechanical Comparison of Suture Button Suspensionplasty Versus Ligament Reconstruction with Tendon Interposition for First Carpometacarpal Arthritis Very Good	Casey Gaskins, III, MD - A Biomechanical Comparison of Suture Button Suspensionplasty Versus Ligament Reconstruction with Tendon Interposition for First Carpometacarpal Arthritis Good	Casey Gaskins, III, MD - A Biomechanical Comparison of Suture Button Suspensionplasty Versus Ligament Reconstruction with Tendon Interposition for First Carpometacarpal Arthritis Fair	Casey Gaskins, III, MD - A Biomechanical Comparison of Suture Button Suspensionplasty Versus Ligament Reconstruction with Tendon Interposition for First Carpometacarpal Arthritis Poor

Question Title

* 15. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers:
Dr. Phillip Spiegel Memorial Visiting Professor- Dr. John Callaghan, MD

	Excellent	Very Good	Good	Fair	Poor
John Callaghan, MD - Why Did We Leave Charnley Hip Replacement	John Callaghan, MD - Why Did We Leave Charnley Hip Replacement Excellent	John Callaghan, MD - Why Did We Leave Charnley Hip Replacement Very Good	John Callaghan, MD - Why Did We Leave Charnley Hip Replacement Good	John Callaghan, MD - Why Did We Leave Charnley Hip Replacement Fair	John Callaghan, MD - Why Did We Leave Charnley Hip Replacement Poor

Question Title

* 16. Please rate the OVERALL EFFECTIVENESS of each of our Orthpaedic Research Day speakers
SESSION VI: ONCOLOGY

	Excellent	Very Good	Good	Fair	Poor
Caroline Chebli, MD - Proximal Humerus Endoprosthesis Following Tumor Resection: Does Synthetic - Mesh Improve Stability and Functional Range of Motion?	Caroline Chebli, MD - Proximal Humerus Endoprosthesis Following Tumor Resection: Does Synthetic - Mesh Improve Stability and Functional Range of Motion? Excellent	Caroline Chebli, MD - Proximal Humerus Endoprosthesis Following Tumor Resection: Does Synthetic - Mesh Improve Stability and Functional Range of Motion? Very Good	Caroline Chebli, MD - Proximal Humerus Endoprosthesis Following Tumor Resection: Does Synthetic - Mesh Improve Stability and Functional Range of Motion? Good	Caroline Chebli, MD - Proximal Humerus Endoprosthesis Following Tumor Resection: Does Synthetic - Mesh Improve Stability and Functional Range of Motion? Fair	Caroline Chebli, MD - Proximal Humerus Endoprosthesis Following Tumor Resection: Does Synthetic - Mesh Improve Stability and Functional Range of Motion? Poor

Question Title

* 17. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers
SESSION VIII: SPORTS

	Excellent	Very Good	Good	Fair	Poor
Rupan Das, MD - Anatomic Coracoclavicular Ligaments as Described by 3-Dimensional Computed Tomography	Rupan Das, MD - Anatomic Coracoclavicular Ligaments as Described by 3-Dimensional Computed Tomography Excellent	Rupan Das, MD - Anatomic Coracoclavicular Ligaments as Described by 3-Dimensional Computed Tomography Very Good	Rupan Das, MD - Anatomic Coracoclavicular Ligaments as Described by 3-Dimensional Computed Tomography Good	Rupan Das, MD - Anatomic Coracoclavicular Ligaments as Described by 3-Dimensional Computed Tomography Fair	Rupan Das, MD - Anatomic Coracoclavicular Ligaments as Described by 3-Dimensional Computed Tomography Poor
Jeff Orr, MD - Biomechanical Comparison of 2 Triple Folding Techniques for the Semitendinosis - Tendon for use in ACL Reconstruction	Jeff Orr, MD - Biomechanical Comparison of 2 Triple Folding Techniques for the Semitendinosis - Tendon for use in ACL Reconstruction Excellent	Jeff Orr, MD - Biomechanical Comparison of 2 Triple Folding Techniques for the Semitendinosis - Tendon for use in ACL Reconstruction Very Good	Jeff Orr, MD - Biomechanical Comparison of 2 Triple Folding Techniques for the Semitendinosis - Tendon for use in ACL Reconstruction Good	Jeff Orr, MD - Biomechanical Comparison of 2 Triple Folding Techniques for the Semitendinosis - Tendon for use in ACL Reconstruction Fair	Jeff Orr, MD - Biomechanical Comparison of 2 Triple Folding Techniques for the Semitendinosis - Tendon for use in ACL Reconstruction Poor
John Groundland, MD - Surgical and Functional Outcomes After Limb-Preservation Surgery for Tumor in - Pediatric Patients	John Groundland, MD - Surgical and Functional Outcomes After Limb-Preservation Surgery for Tumor in - Pediatric Patients Excellent	John Groundland, MD - Surgical and Functional Outcomes After Limb-Preservation Surgery for Tumor in - Pediatric Patients Very Good	John Groundland, MD - Surgical and Functional Outcomes After Limb-Preservation Surgery for Tumor in - Pediatric Patients Good	John Groundland, MD - Surgical and Functional Outcomes After Limb-Preservation Surgery for Tumor in - Pediatric Patients Fair	John Groundland, MD - Surgical and Functional Outcomes After Limb-Preservation Surgery for Tumor in - Pediatric Patients Poor

Question Title

* 18. Based on your CME needs, please give suggestions for future program topics/formats.

Question Title

* 19. What barriers do you foresee that may hinder your implementation of changes learned at this activity? What educational strategies could help to overcome these barriers?

Question Title

* 20. What do you see as your BIGGEST challenge in improving patient safety, patient care and/or patient outcomes? What educational strategies could help to overcome this challenge?

Question Title

* 21. How did you hear about this CME Program?

Direct Mail

Eblast

Phone Call

Course Catalog

Orthopedics Today/Orthopedics Ad

Social Media (Facebook/Twitter)

Referral (Please list below)

Other (please specify)

Question Title

* 22. Please provide your contact information.

Full Name:

Degree:

Email Address:

Phone Number:

Question Title

* 23. The Foundation for Orthopaedic Research and Education (FORE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. FORE designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For the purpose of recertification, the following organizations accept AMA PRA Category 1 Credits^TMfrom organizations accredited by the ACCME.

American Academy of Physician Assistants (AAPA)

American Nurses Credentialing Center (ANCC)

American Academy of Neurosurgeons (AANS)

Please attest to the total number of credit hours (minimum .25- maximum 5.5) that you spent in this CME activity:

Question Title

* 1. Check appropriate title.

Question Title

* 2. Please rate your overall satisfaction with the organization of this meeting.

Question Title

* 3. The ACCME defines commercial bias as presentations giving an unbalanced view of therapeutic options by promoting a specific proprietary business interest of a commercial interest. Was this CME course free of commercial bias?

Question Title

* 4. Did the faculty disclose significant relationships with commercial support? (One or more of these methods: Syllabus / Opening Remarks / Verbally / On Slides)

Question Title

* 5. Please rate the quality of the meeting facilities.

Question Title

* 6. How well were the Orthopaedic Research Day course objectives met?Upon completion of the course participants should be able to:

Question Title

* 7. Did you meet your personal goal/objective for what you intended to get out of this course?

Question Title

* 8. Do you intend to integrate what you learned at this conference into your current practice?

Question Title

* 9. Please rate the relevance of this program to your scope of practice:

Question Title

* 10. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakersSESSION I: JOINTS

Question Title

* 11. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakersSESSION II: SHOULDER & ELBOW

Question Title

* 12. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers Session III: TRAUMA

Question Title

* 13. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakersSESSION V: FOOT & ANKLE

Question Title

* 14. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakersSESSION V: UPPER EXTREMITY

Question Title

* 15. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers:Dr. Phillip Spiegel Memorial Visiting Professor- Dr. John Callaghan, MD

Question Title

* 16. Please rate the OVERALL EFFECTIVENESS of each of our Orthpaedic Research Day speakersSESSION VI: ONCOLOGY

Question Title

* 17. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakersSESSION VIII: SPORTS

Question Title

* 18. Based on your CME needs, please give suggestions for future program topics/formats.

Question Title

* 19. What barriers do you foresee that may hinder your implementation of changes learned at this activity? What educational strategies could help to overcome these barriers?

Question Title

* 20. What do you see as your BIGGEST challenge in improving patient safety, patient care and/or patient outcomes? What educational strategies could help to overcome this challenge?

Question Title

* 21. How did you hear about this CME Program?

Question Title

* 22. Please provide your contact information.

Question Title

* 3. The ACCME defines commercial bias as presentations giving an unbalanced view of therapeutic options by promoting a specific proprietary business interest of a commercial interest.

Was this CME course free of commercial bias?

* 4. Did the faculty disclose significant relationships with commercial support?
(One or more of these methods: Syllabus / Opening Remarks / Verbally / On Slides)

* 6. How well were the Orthopaedic Research Day course objectives met?

Upon completion of the course participants should be able to:

* 10. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers
SESSION I: JOINTS

* 11. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers
SESSION II: SHOULDER & ELBOW

* 13. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers
SESSION V: FOOT & ANKLE

* 14. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers
SESSION V: UPPER EXTREMITY

* 15. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers:
Dr. Phillip Spiegel Memorial Visiting Professor- Dr. John Callaghan, MD

* 16. Please rate the OVERALL EFFECTIVENESS of each of our Orthpaedic Research Day speakers
SESSION VI: ONCOLOGY

* 17. Please rate the OVERALL EFFECTIVENESS of each of our Orthopaedic Research Day speakers
SESSION VIII: SPORTS